Malondialdehyde in early phase of acute pancreatitis

Revista Espanola de Enfermedades Digestivas

Volumn 103, Issue 11, 2011, Pages 563-569

  Hernández, Vicent ^a   Miranda, María ^b   Pascual, Isabel ^a   Sánchiz, Vicente ^a   Almela, Pedro ^a   Añón, Ramón ^a   Cuadrado, Esperanza ^a   Sanz, María Isabel ^a   Mínguez, Miguel ^a   Mora, Francisco ^a   Romero, Francisco Javier ^b   Benages, Adolfo ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

Author keywords

Acute pancreatitis; Complications; Malondialdehyde; Oxidative stress

Indexed keywords

MALONALDEHYDE;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; EVOLUTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RANK SUM TEST;

EID: 82755161099     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082011001100002     Document Type: Article

References (36)

1. Bradley EL. A clinically based classification system for acute pancreatitis. Arch Surg 1993;128:586-90.
2. Braganza JM. Towards a novel treatment strategy for acute pancreatitis. Reappraisal of the evidence on aetiogenesis. Digestion 2001;63:69-91.
3. Norman JG. New approaches to acute pancreatitis: Role of inflammatory mediators. Digestion 1999; 60 (suppl 1):57-60.
4. Sanfey H, Bulkley GB, Cameron JL. The role of oxygen free radicals in the pathogenesis of acute pancreatitis. Ann Surg 1984;200:405-12.
5. Scott P, Bruce C, Schofield D, Shiel N, Braganza JM, McCloy RF. Vitamin C status in patients with acute pancreatitis. Br J Surg 1993; 80: 750-4.
6. Braganza JM, Scott P, Bilton D, Schofield D, Chaloner C, Shiel N, et al. Evidence of early oxidative stress in acute pancreatitis. Clues for correction. Int J Pancreatol 1995;17:69-81.
7. Tsai K, Wang SS, Chen TS, Kong CW, Chang FY, Lee SD, et al. Oxi-dative stress: an important phenomenon with pathogenic significance in the progression of acute pancreatitis. Gut 1998;42:850-5.
8. Wereszczynska-Seimiatkowska U, Dabrowski, A, Jedynak M, Gabr-yelewicz A. Oxidative Stress as an early prognostic factor in acute pancreatitis (AP): its correlation with serum phospholipase A2 (PLA2) and plasma polymorphonuclear elastase (PMN-E) in different-severity forms of human AP. Pancreas 1998;17:163-8.
9. Curran FJ, Sattar N, Talwar D, Baxter JN, Imrie CW. Relationship of carotenoid and vitamins A and E with the acute inflammatory response in acute pancreatitis. Br J Surg 2000;87:301-5.
10. Park BK, Chung JB, Lee JH, Suh JH, Park SW, Song SY, et al. Role of free radicals in patients with acute pancreatitis. World J Gastroenterol 2003;9:2266-9.
11. Winterbourn CC, Bonjam MJ, Buss J, Abu-Zidan FM, Windsor JA. Elevated protein carbonyls as plasma markers of oxidative stress in acute pancreatitis. Pancreatology 2003;3:375-82.
12. Wereszczynska-Seimiatkowska U, Mroczko D, Siemiatkowski A, Szmitkowski M, Borawska M, Kosel J. The importance of interleukin 18, glutathione peroxidase, and selenium concentration changes in acute pancreatitis. Dig Dis Sci 2004;49:642-50.
13. Rahman SH, Ibrahim K, Larvin M, Kingsnorth A, McMahon MJ. Association of antioxidant enzyme gene polymorphisms and glutathione status with severe acute pancreatitis. Gastroenterology 2004;126:1312-22.
14. Dziurkowska-Marek A, Marek TA, Nowak A, Kacperek-Hartleb T, Wierka D, Nowakowska-Dulawa E. The dynamics of oxidant/antioxi-dant balance in the early phase of human acute biliary pancreatitis. Pan-creatology 2004;4:215-22.
15. Thareja S, Bhardwaj P, Sateesh J, Saraya A. Variations in the levels of oxidative stress and antioxidants during early acute pancreatitis. Trop Gastroenterol 2009;30:26-31.
16. Bonham MJ, Abu-Zidan FM, Simovic MO, Sluis KB, Wilkinson A, Winterbourn CC, et al. Early ascorbic acid depletion is related to the severity of acute pancreatitis. Br J Surg 1999;86:1296-301.
17. Abu-Zidan FM, Bonham MJ, Windsor JA. Severity of acute pancreatitis: a multivariate analysis of oxidative stress markers and modified Glasgow criteria. Br J Surg 2000;87:1019-23.
18. Halliwell B. Oxidative stress markers in human disease: application to diabetes and to evaluation of the effects of antioxidants. In: Antioxidants in Diabetes Management. Packer L, Rosen P, Tritschler HJ, King GL, Azzi A, eds. Marcel Dekker INC. New York 2000:33-52.
19. Du WD, Yuan ZR, Sun J, Tang JX, Cheng AQ, Shen DM, et al. Therapeutic efficacy of high-dose vitamin C on acute pancreatitis and its potential mechanisms. World J Gastroenterol 2003;9:2565-9.
20. Sajewicz W, Milnerowicz S, Nabzdyk S. Blood plasma antioxidant defense in patients with pancreatitis. Pancreas 2006;32:139-44.
21. Abu-Hilal M, McPhail MJW, Marchand L, Johnson CD. Malondial-dehyde and superoxide dismutase as potential markers of severity in acute pancreatitis. JOP 2006;7:185-92.
22. Richard MJ, Guiraud P, Meo J, Favier A. High performance liquid chromatography separation of malondialdehyde thiobarbituric acid adduct in biological materials (plasma and human cell) using a commercially available reagent. J. Chromatogr 1992;577:9-18.
23. Romero MJ, Bosch-Morell F, Romero B, Rodrigo JM, Serra MA, Romero FJ. Serum malondialdehyde: possible use for the clinical management of chronic hepatitis C patients. Free Radic Biol Med 1998; 25:993-7.
24. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998;175:76-83.
25. Shi C, Andersson R, Wang X. Potential role of reactive oxygen species in pancreatitis-associated multiple organ dysfunction. Pancreatology 2005;5:492-500.
26. United Kingdom guidelines for the management of acute pancreatitis. UK Working Party on Acute Pancreatitis. Gut 2005;54 (suppl 3):iii1-iii9.
27. United Kingdom guidelines for the management of acute pancreatitis. Gut 1998; 42(suppl 2):S1-S13.
28. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biol Med 1990;9:515-40.
29. Salaris SC, Babbs CF. A rapid, widely applicable screen for drugs that suppress free radical formation in ischemia/reperfusion. J Pharmacol Methods 1988;20:335-45.
30. Young IS, Trimble ER. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 1991;28:504-8.
31. Lujano-Nicolás LA, Pérez-Hernández JL, Durán-Pérez EG, Serralde-Zúñiga AE. Correlation among clinical, biochemical and tomographic criteria in order to evaluate the severity in acute pancreatitis. Rev Esp Enferm Dig 2010;102:376-80
32. Buter A, Imrie CW, Carter CR, Evans S, Mckay CJ. Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg 2002;89:298-302.
33. Johnson CD, Abu-Hilal M. Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut 2004;53:1340-4.
34. Halonen KI, Pettila V, Leppaniemi AK, Kemppainen EA, Puolakkainen PA, Haapiainen RK. Multiple organ dysfunction associated with severe acute pancreatitis. Crit Care Med 2002;30:1274-79.
35. Mofidi R, Duff MD, Wigmore SJ, Madhavan KK, Garden OF, Parks RW. Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg 2006;93:738-44.
36. Siriwardena AK, Mason JM, Balachandra S, Bagul A, Galloway S, Formela L, et al. Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis. Gut 2007;56:1439-44.